Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 160
Filter
1.
Br J Cancer ; 109(8): 2248-58, 2013 Oct 15.
Article in English | MEDLINE | ID: mdl-24045665

ABSTRACT

BACKGROUND: Epithelial-mesenchymal transition (EMT) is a crucial process in cancer progression that provides cancer cells with the ability to escape from the primary focus, invade stromal tissues and migrate to distant regions. Cell lines that lack E-cadherin show increased tumorigenesis and metastasis, and the expression levels of E-cadherin and Snail correlate inversely with the prognosis of patients suffering from breast cancer or oral squamous cell carcinoma (OSCC). Moreover, recent studies have shown that most EMT cases are regulated by soluble growth factors or cytokines. Among these factors, fibroblast growth factors (FGFs) execute diverse functions by binding to and activating members of the FGF receptor (FGFR) family, including FGFR1-4. Fibroblast growth factor receptor 1 is an oncoprotein that is involved in tumorigenesis, and PD173074 is known to be a selective inhibitor of FGFR1. However, the roles of FGFR1 and FGFR1 inhibitors have not yet been examined in detail. METHODS: Here, we investigated the expression of FGFR1 in head and neck squamous cell carcinoma (HNSCC) and the role of the FGFR1 inhibitor PD173074 in carcinogenesis and the EMT process. RESULTS: Fibroblast growth factor receptor 1 was highly expressed in 54% of HNSCC cases and was significantly correlated with malignant behaviours. Nuclear FGFR1 expression was also observed and correlated well with histological differentiation, the pattern of invasion and abundant nuclear polymorphism. Fibroblast growth factor receptor 1 was also overexpressed in EMT cell lines compared with non-EMT cell lines. Furthermore, treatment of HOC313 cells with PD173074 suppressed cellular proliferation and invasion and reduced ERK1/2 and p38 activation. These cells also demonstrated morphological changes, transforming from spindle- to cobble stone-like in shape. In addition, the expression levels of certain matrix metalloproteinases (MMPs), whose genes contain activator protein-1 (AP-1) promoter sites, as well as Snail1 and Snail2 were reduced following PD173074 treatment. CONCLUSION: Taken together, these data suggest that PD173074 inhibits the MAPK pathway, which regulates the activity of AP-1 and induces MET. Furthermore, this induction of MET likely suppresses cancer cell growth and invasion.


Subject(s)
Carcinoma, Squamous Cell/drug therapy , Epithelial-Mesenchymal Transition/drug effects , Head and Neck Neoplasms/drug therapy , Pyrimidines/pharmacology , Receptor, Fibroblast Growth Factor, Type 1/antagonists & inhibitors , Receptor, Fibroblast Growth Factor, Type 1/biosynthesis , Transcription Factor AP-1/metabolism , Carcinoma, Squamous Cell/enzymology , Carcinoma, Squamous Cell/metabolism , Carcinoma, Squamous Cell/pathology , Cell Growth Processes/drug effects , Cell Line, Tumor , Cell Nucleus/metabolism , Glycogen Synthase Kinase 3/metabolism , Glycogen Synthase Kinase 3 beta , Head and Neck Neoplasms/enzymology , Head and Neck Neoplasms/metabolism , Head and Neck Neoplasms/pathology , Humans , Immunohistochemistry , Mitogen-Activated Protein Kinases/metabolism , Neoplasm Invasiveness , Proto-Oncogene Proteins c-met/biosynthesis , Squamous Cell Carcinoma of Head and Neck , Transcription Factor AP-1/biosynthesis
2.
J Neuroendocrinol ; 22(7): 818-24, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20456607

ABSTRACT

Orexin is a neuropeptide produced by a specific subset of neurones located in the lateral hypothalamic area. Mice lacking either prepro-orexin or orexin receptor 2, as well as those in which orexin-producing neurones (orexin neurones) are deleted, share a common phenotype: altered sleep-wake regulation and the sudden onset of muscle atonia. These symptoms are similar to the human sleep disorder narcolepsy. In this review, we describe recent advances in the study of orexin function with a particular emphasis on microscopic techniques that better characterise the neuronal networks involving orexin neurones, as well as recent optogenetic approaches that allow for the activation or inhibition of specific neurones by expressing different light-activated proteins. In particular, the use of orexin/halorhodopsin and orexin/channelrhodopsin-2 transgenic mice has demonstrated an important role for orexin neurones in regulating the sleep-wake cycle and state of arousal in vivo. Further refinement of these in vitro and in vivo techniques will allow for a more detailed understanding of the interaction of orexin with other neurotransmitter pathways in the brain.


Subject(s)
Intracellular Signaling Peptides and Proteins/metabolism , Neural Pathways/physiology , Neuropeptides/metabolism , Receptors, G-Protein-Coupled/metabolism , Receptors, Neuropeptide/metabolism , Animals , Humans , Hypothalamic Area, Lateral/metabolism , Intracellular Signaling Peptides and Proteins/genetics , Neural Pathways/anatomy & histology , Neurons/cytology , Neurons/metabolism , Neuropeptides/genetics , Orexin Receptors , Orexins , Patch-Clamp Techniques , Photic Stimulation , Receptors, G-Protein-Coupled/genetics , Receptors, Neuropeptide/genetics
3.
Biochem Soc Trans ; 33(Pt 6): 1337-40, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16246113

ABSTRACT

Adenylate cyclase is a membrane-bound enzyme that catalyses the conversion of ATP into cAMP upon activation of cell-surface G-protein-coupled receptors, such as beta-adrenergic receptors, and initiates a cascade of phosphorylation reactions within the cell. Type 5 adenylate cyclase is a major isoform in the heart as well as in the striatum of the brain. Mice with a disrupted type 5 adenylate cyclase gene exhibited normal cardiac function under basal conditions, but a decreased response to isoprenaline stimulation. When mice were subjected to pressure overload stress with aortic banding, they developed cardiac hypertrophy, but with a significant reduction in the number of apoptotic cardiac myocytes as well as preserved cardiac function. When type 5 adenylate cyclase activity was inhibited pharmacologically, by the use of a novel P-site inhibitor with enhanced selectivity for this isoform, there were no changes in cardiac myocyte contractility, but the development of cardiac myocyte apoptosis induced by isoprenaline stimulation was effectively prevented. These results indicate that type 5 adenylate cyclase may serve as a better target of pharmacotherapy to prevent the development of cardiac myocyte apoptosis and thus failure in response to various cardiac stresses.


Subject(s)
Adenylyl Cyclases/metabolism , Cyclic AMP/metabolism , Isoenzymes/metabolism , Myocardium/enzymology , Second Messenger Systems/physiology , Adenylyl Cyclases/genetics , Animals , Heart/innervation , Isoenzymes/genetics , Mice , Mice, Knockout
5.
Immunology ; 94(2): 142-8, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9741334

ABSTRACT

Although existence of suppressor T cells is a controversial issue in cellular immunology, several lines of evidence indicate that T-cell-receptor alpha-chain (TCR-alpha) is a critical component of suppressor factors produced by these cells. Monoclonal non-specific suppressor factor (MNSF), a lymphokine produced by murine T-cell hybridoma, possesses pleiotrophic antigen-non-specific suppressive functions. Recently, we have shown that the 70,000-MW MNSF comprises an 8000-MW ubiquitin-like polypeptide and other subunit(s). Here we report that the 8000-MW ubiquitin homologue is associated with an intracellular TCR-alpha (but not TCR-beta)-like molecule and released from the cells. The affinity eluates obtained from the culture supernatants of E17 cells and concanavalin A (Con A)-activated splenocytes with anti-TCR-alpha monoclonal antibody (mAb) showed an antigen-non-specific, major histocompatibility complex (MHC)-non-restricted suppression. Immunoblot analysis demonstrated that anti-TCR-alpha, but not anti-TCR-beta, mAb recognizes native 70,000-MW MNSF. In addition, we found the dissociation of the 8000-MW polypeptide from the 62,000-MW TCR-alpha cross-reactive protein by hydrolase which cleaves isopeptide bonds. Thus the covalent attachment of ubiquitin-like protein(s) may be involved in the underlying mechanism of suppressor T-cells and TCR-alpha-like molecule(s) might be a main link between antigen-specific and non-specific suppression.


Subject(s)
Immune Tolerance , Receptors, Antigen, T-Cell, alpha-beta/immunology , Ubiquitins/immunology , Animals , Carbon-Nitrogen Lyases/isolation & purification , Carbon-Nitrogen Lyases/metabolism , Carbon-Nitrogen Lyases/pharmacology , Cell Culture Techniques , Concanavalin A/immunology , Female , Mice , Mice, Inbred BALB C , Mice, Inbred C3H , Mice, Inbred C57BL , Molecular Weight , Spleen/enzymology , Spleen/immunology , Suppressor Factors, Immunologic/chemistry , Suppressor Factors, Immunologic/immunology
6.
Clin Exp Pharmacol Physiol ; 23(3): 236-40, 1996 Mar.
Article in English | MEDLINE | ID: mdl-8934614

ABSTRACT

1. The effects of a formula of traditional Chinese medicine, TBL-1, on collagen-induced arthritis (CIA) were investigated in DBA/1J mice. 2. From 4 weeks after the first immunization with bovine type II collagen (CII), TBL-1 or indomethacin was administered orally for 13 weeks. 3. Clinical scores of CIA were decreased by both TBL-1 and indomethacin intervention compared with the control CII-immunized group. 4. Radiographic scores of phalangeal destruction were markedly improved by TBL-1 intervention (P < 0.001), but indomethacin failed. 5. The suppressive effects of TBL-1, but not indomethacin, were manifested in reduced serum anti-CII antibody titres (P < 0.001). 6. These findings suggest that TBL-1 may play a role in regulating some immune responses in the present arthritis model.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Arthritis/drug therapy , Drugs, Chinese Herbal/therapeutic use , Foot/pathology , Animals , Arthritis/chemically induced , Arthritis/physiopathology , Autoantibodies/biosynthesis , Collagen , Forelimb/pathology , Hindlimb/pathology , Indomethacin/therapeutic use , Male , Mice , Mice, Inbred DBA
7.
Proc Natl Acad Sci U S A ; 92(8): 3463-7, 1995 Apr 11.
Article in English | MEDLINE | ID: mdl-7724584

ABSTRACT

The monoclonal nonspecific suppressor factor (MNSF) is a lymphokine product of a murine T-cell hybridoma that inhibits the generation of lipopolysaccharide-induced immunoglobulin-secreting cells in an antigen-nonspecific manner. A cDNA clone encoding MNSF beta (an isoform of MNSF) was isolated and expressed in bacteria. The sequence obtained is virtually identical to the Fau protein, a product of the ubiquitously expressed fau gene with unknown function. Northern blot analysis demonstrated a single, 0.6-kb transcript. Specific polyclonal antibodies against synthetic peptides corresponding to the deduced amino acid sequences were elicited in rabbits. Immunoprecipitation experiments with these antibodies showed that MNSF beta is released extracellularly in an aggregate form, albeit it lacks a signal peptide sequence. The anti-MNSF beta affinity eluate from the MNSF-producing murine hybridoma (E17) and concanavalin A-activated splenocyte culture supernatants inhibited the immunoglobulin production by lipopolysaccharide-activated splenocytes. Recombinant MNSF beta also showed a similar biologic activity. Thus, ubiquitin-like protein(s) may be involved in the regulation of the immune responses.


Subject(s)
Suppressor Factors, Immunologic/genetics , Suppressor Factors, Immunologic/pharmacology , Amino Acid Sequence , Animals , Base Sequence , Biological Assay , DNA, Complementary/genetics , Immune Tolerance , Immunoblotting , Mice , Mice, Inbred AKR , Mice, Inbred BALB C , Molecular Sequence Data , Precipitin Tests , Recombinant Proteins/pharmacology , Ribosomal Proteins/genetics , Sequence Homology, Amino Acid , Spleen/cytology , Spleen/drug effects , Suppressor Factors, Immunologic/immunology
8.
Mech Ageing Dev ; 78(2): 145-54, 1995 Mar 01.
Article in English | MEDLINE | ID: mdl-7596195

ABSTRACT

In order to evaluate the expression of antinuclear antibodies (ANA) in normal elderly individuals over time and clinical significance, a cross-sectional ANA testing in healthy Japanese was performed, followed by annual evaluations of ANA positive aged (> or = 65 years) and a control group. ANA was more prevalent in the aged (11.4% vs. 3.8%) and most were persistent after 4 years. Anti-ssDNA and anti-histone antibodies were increased in aged ANA positive as compared to ANA negative controls. Except for a history of spontaneous abortion, there was no differences in clinical findings. HLA DRB1*0901 and the DQB1*0602 + 0302 + 0303 set of alleles were increased in ANA positive. Therefore, ANA in the aged were persistent, apparently directed toward chromatin elements, and shared MHC associations with autoimmune diseases. Longer follow-up may be necessary to improve the evaluation of clinical significance of ANA in the aged.


Subject(s)
Aging/immunology , Antibodies, Antinuclear/immunology , Adult , Age Factors , Aged , Autoimmunity/immunology , Cross-Sectional Studies , DNA Probes , Female , Follow-Up Studies , Humans , Immunoglobulin G/blood , Immunoglobulin M/blood , Major Histocompatibility Complex/immunology , Male , Middle Aged , Prospective Studies
9.
Leuk Lymphoma ; 14(1-2): 171-80, 1994 Jun.
Article in English | MEDLINE | ID: mdl-7920226

ABSTRACT

We examined c-myc protein expression in cell cycle phases during differentiation induction of HL-60 cells by flow cytometry using an indirect immunofluorescence method. In exponentially proliferating HL-60 cells, c-myc protein was expressed in a cell cycle dependent manner. During the differentiation induction of HL-60 cells with dimethylsulfoxide (DMSO), c-myc protein was rapidly down-regulated in the G1/0 specific phase prior to the appearance of differentiation associated markers. Our results indicate that c-myc protein functions in the G1/0 specific phase in cellular differentiation, and the rapid down-regulation of c-myc protein in G1/0 phase is closely associated with initial differentiation programs.


Subject(s)
Gene Expression Regulation, Leukemic , Leukemia, Promyelocytic, Acute/pathology , Neoplasm Proteins/biosynthesis , Proto-Oncogene Proteins c-myc/biosynthesis , Cell Cycle , Cell Differentiation/drug effects , Cell Division , Dimethyl Sulfoxide/pharmacology , Flow Cytometry , Fluorescent Antibody Technique , Humans , Male , Neoplasm Proteins/genetics , Proto-Oncogene Proteins c-myc/genetics , Tumor Cells, Cultured/drug effects
10.
J Immunol ; 152(5): 2624-32, 1994 Mar 01.
Article in English | MEDLINE | ID: mdl-8133068

ABSTRACT

The monoclonal nonspecific suppressor factor (MNSF) is a lymphokine produced by a murine T cell hybridoma capable of suppressing Ab production by LPS-stimulated B cells. The existence of a human counterpart of MNSF, designated as the human nonspecific suppressor factor (hNSF), was likely because the anti-MNSF mAb (MO6) recognizes a similar suppressive activity in supernatants of Con A-stimulated human PBMC. By using the MO6 mAb, we investigated the presence of hNSF in the ascitic fluid of a patient with SLE. A small amount of cross-reactive hNSF was isolated from concentrated ascitic fluid fractionated with the MO6-affinity column, and a specific anti-hNSF mAb (P2) was produced. The hNSF eluted from the P2-affinity column could suppress up to 80% of the PWM-induced IgG production of human PBMC in a dose-dependent manner, even when added in late culture periods. Moreover, hNSF could inhibit proliferation of PBMC triggered by either PWM or Con A, which also implies an effect on T cells. On SDS-PAGE, the isolated hNSF resolved as a single peak of about 66 kDa and probably represents an aggregate of hydrophobic subunits. On reverse-phase HPLC, the bioactivity could be recovered from a single peak at 18.3 min. The suppression of IgG production induced by hNSF could be partly neutralized by preincubation with an anti-TCR-alpha mAb, whereas an anti-TCR-beta did not have any effect. Anti-TCR-alpha could also directly bind to the isolated nNSF, demonstrating some serologic relationship, as has been reported for several Ag-specific suppressor systems.


Subject(s)
Ascitic Fluid/immunology , Lupus Erythematosus, Systemic/immunology , Suppressor Factors, Immunologic/isolation & purification , Adult , Animals , Chromatography, High Pressure Liquid , Electrophoresis, Gel, Two-Dimensional , Female , Humans , Isoelectric Point , Mice , Molecular Weight , Receptors, Antigen, T-Cell, alpha-beta/immunology , Species Specificity , Suppressor Factors, Immunologic/chemistry
11.
Gerontology ; 40(5): 279-85, 1994.
Article in English | MEDLINE | ID: mdl-7959085

ABSTRACT

We investigated the effects of pacemaker implantation on cerebral blood flow and cognitive function in 14 severely bradycardic patients (mean age 75.2 years). Cerebral blood flow and verbal intelligence improved after the pacemaker implantation. Systolic and mean arterial blood pressure was significantly reduced after the implantation. Changes in cerebral blood flow significantly correlated with changes in heart rate in polynomial regression analysis, but not with changes in cardiac output. Before the implantation, verbal cognitive function was lower in bradycardic patients than in age-matched control subjects, and brain CT showed significant advanced atrophy in these patients. However, verbal cognitive function was also improved after the implantation. Pacemaker implantation in the severe bradycardic elderly should be beneficial not only for cardiac function but also for brain function. We concluded that these results suggest that heart rate is one of the important factors in the regulation of cerebral circulation in patients with severe bradycardia. Pacemaker implantation in the elderly improved quality of life and may prevent mental deterioration.


Subject(s)
Bradycardia/physiopathology , Bradycardia/therapy , Cerebrovascular Circulation , Cognition , Pacemaker, Artificial , Aged , Aged, 80 and over , Blood Pressure , Bradycardia/psychology , Creatinine/blood , Electroencephalography , Female , Humans , Intelligence , Male , Middle Aged , Quality of Life , Tomography, X-Ray Computed , Vascular Resistance
12.
Nihon Eiseigaku Zasshi ; 48(5): 992-9, 1993 Dec.
Article in Japanese | MEDLINE | ID: mdl-8107302

ABSTRACT

To clarify the alteration of serum immunoglobulin levels with age, serum immunoglobulin and other parameters (age, symptoms, blood biochemical parameters, etc.) of inhabitants (213 persons; 63 men, 150 women) of a remote island in Shimane Prefecture were studied. Their subjective symptoms were collected by means of a questionnaire and various blood parameters were measured. These data were analyzed by t-test and multivariate analysis. The IgM level was decreased with age and each immunoglobulin level correlated with the total-protein level in serum. The IgG level of the subjects feeling fatigue was higher than that of the subjects not feeling fatigue.


Subject(s)
Immunoglobulins/blood , Adult , Aged , Aging/immunology , Fatigue/immunology , Female , Humans , Japan , Male , Middle Aged , Multivariate Analysis , Surveys and Questionnaires
13.
Br J Haematol ; 85(4): 805-7, 1993 Dec.
Article in English | MEDLINE | ID: mdl-7918048

ABSTRACT

We successfully treated two patients with refractory idiopathic thrombocytopenic purpura (ITP) with a weekly or monthly administration of alpha-interferon followed by short-course treatment with alpha-interferon. In both cases an increase in platelet count was brought about within 1 week after administration of alpha-interferon and the favourable response in platelet count was sustained over a few years with the weekly or monthly administration of alpha-interferon in the absence of any noticeable side-effects except for fever. So, alpha-interferon therapy seems to be beneficial in some cases of refractory ITP in terms of both remission induction and maintenance therapy.


Subject(s)
Interferon-alpha/therapeutic use , Purpura, Thrombocytopenic, Idiopathic/therapy , Aged , Drug Administration Schedule , Female , Humans , Interferon-alpha/administration & dosage , Long-Term Care , Middle Aged , Platelet Count
15.
Stroke ; 23(12): 1716-22, 1992 Dec.
Article in English | MEDLINE | ID: mdl-1448820

ABSTRACT

BACKGROUND: We studied 60 patients longitudinally to examine relations between regional cerebral blood flow and depressive states after stroke. METHODS: Poststroke depressive states were assessed by the Zung Self-Rating Depression Scale (SDS). Regional cerebral blood flow was measured using the 133xenon inhalation method with patients in the resting state on the same day as the SDS assessment. All patients were followed for an average of 14 months after the initial assessment. RESULTS: Severity of depression was inversely correlated with regional cerebral blood flow values in the parieto-occipital regions of the right hemisphere and in the anterior temporal region of the left hemisphere at the initial evaluation. Patients with lesions in left frontal or right parieto-occipital regions were more depressive in comparison with those with other brain lesions. Follow-up study showed significant inverse correlations between changes in SDS score and changes in regional cerebral blood flow at all scalp sites. Furthermore, higher inverse correlations were observed at specific brain regions in each hemisphere, including the parietal and parieto-occipital regions of the right hemisphere and the anterior temporal and inferior frontal regions of the left hemisphere. This relation was independent of recovery from neurological deficits. CONCLUSIONS: These results suggest that dysfunction of specific cortical and subcortical regions in both hemispheres asymmetrically contributes to depressive state after stroke.


Subject(s)
Cerebrovascular Circulation , Cerebrovascular Disorders/psychology , Depression/etiology , Affect , Aged , Depression/physiopathology , Female , Humans , Longitudinal Studies , Male , Middle Aged , Psychiatric Status Rating Scales , Self-Assessment
16.
Angiology ; 43(10): 801-9, 1992 Oct.
Article in English | MEDLINE | ID: mdl-1476267

ABSTRACT

UNLABELLED: The effect of nilvadipine, a newly developed calcium antagonist, on regional cerebral blood flow (rCBF) was investigated in 7 patients with chronic cerebral infarction. rCBF was measured by the 133Xenon inhalation method. Patients were given a single dose of 4 mg of nilvadipine after the first measurement of rCBF, and the second measurement was done one hour after the administration. All patients had hemiparesis and 2 of them had mild to moderate mental deterioration, but all patients could walk to the outpatient clinic by themselves. RESULTS: (1) rCBF of the affected side significantly increased by 22.7% after single oral administration of nilvadipine (p < 0.05). The increase of rCBF was significantly marked in frontal regions of the affected hemispheres. (2) No significant changes in blood pressure or end tidal partial pressure of carbon dioxide were observed during the examination. These results indicate that nilvadipine has a potent selective vasodilatory action on the cerebral arteries in patients with cerebral infarction.


Subject(s)
Calcium Channel Blockers/administration & dosage , Cerebral Infarction/physiopathology , Cerebrovascular Circulation/drug effects , Nifedipine/analogs & derivatives , Administration, Oral , Aged , Aged, 80 and over , Blood Pressure/drug effects , Calcium Channel Blockers/pharmacology , Cerebral Infarction/diagnostic imaging , Chronic Disease , Female , Humans , Male , Middle Aged , Nifedipine/administration & dosage , Nifedipine/pharmacology , Radionuclide Imaging
17.
Nihon Ronen Igakkai Zasshi ; 29(7-8): 591-5, 1992.
Article in Japanese | MEDLINE | ID: mdl-1434057

ABSTRACT

A 73-year-old man was admitted with gait disturbance and dysarthria. He showed right-side cerebellar ataxia. Computed tomography of brain showed left thalamic bleeding. Nine months later, he was admitted again because of seizure and consciousness disturbance. He had a history of diabetes mellitus and gout for five years, but no hypertension. On physical examination the lungs and heart were normal. On neurological examination, he showed stupor,pupils and eye position were normal. He showed right hemiparesis and urinary incontinence. The deep tendon reflexes were (+) at the upper limbs and (2+) at the right knee and ankle. Blood pressure was 162/88 mmHg and glucose was 275 mg/dl. Other laboratory data were normal. Brain CT showed hemorrhage of the left frontal lobe. The cystatin C level in cerebrospinal fluid was 68 ng/ml. Therefore we suspected cystatin C deposit amyloid angiopathy. In this case, thalamic hemorrhage was initially thought to be amyloid angiopathy. In cases of cerebral hemorrhage in the elderly without hypertension, we must be considered amyloid angiopathy.


Subject(s)
Cerebral Amyloid Angiopathy/diagnosis , Cerebral Hemorrhage/etiology , Cystatins/cerebrospinal fluid , Aged , Cerebral Amyloid Angiopathy/cerebrospinal fluid , Cerebral Amyloid Angiopathy/complications , Cystatin C , Humans , Male , Recurrence
18.
Nihon Ronen Igakkai Zasshi ; 29(3): 179-84, 1992 Mar.
Article in Japanese | MEDLINE | ID: mdl-1593787

ABSTRACT

In order to clarify the influence of living alone on depressed mood and subjective sensation of well-being in the elderly, we studied 113 elderly (60 years old or more) living in Chibu village on Oki island. The subjects were divided into two groups, 33 subjects (Single group) who were living alone (mean age 74.1 years) and 80 subjects (Married group) who were married and lived with their spouses (mean age 69.0 years). For the measurement of depressed mood and subjective sensation of well-being the Zung Self-Rating Depression Scale (SDS) and Morale Scale were used. The SDS score of the Single group was significantly higher than that of the Married group. The incidence of depression was higher in the Single group than in the Married group, but the difference was not of statistical significance. The Morale Scale score in the Single group was significantly higher than in the Married group. Subjects in the Single group felt more lonely than those in the Married group, but not significantly so. There was a highly significant correlation between the SDS score and the Morale scale score. We concluded that, in the elderly, living alone is more depressing and less satisfying than living with a partner.


Subject(s)
Aging/psychology , Depression/epidemiology , Affect , Aged , Humans , Incidence , Japan/epidemiology , Marriage , Middle Aged , Single Person , Test Anxiety Scale
19.
J Rheumatol ; 19(3): 424-30, 1992 Mar.
Article in English | MEDLINE | ID: mdl-1578458

ABSTRACT

We have attempted to design classification criteria for adult Still's disease by analyzing the data obtained through a multicenter survey of 90 Japanese patients with this disease and of 267 control patients. The proposed criteria consisted of fever, arthralgia, typical rash, and leukocytosis as major, and sore throat, lymphadenopathy and/or splenomegaly, liver dysfunction, and the absence of rheumatoid factor and antinuclear antibody as minor criteria. Requiring 5 or more criteria including 2 or more major criteria yielded 96.2% sensitivity and 92.1% specificity. However, an exclusion process will be needed for an accurate classification, since this disease is relatively rare.


Subject(s)
Still's Disease, Adult-Onset/classification , Adolescent , Adult , Female , Humans , Male , Prevalence , Sensitivity and Specificity , Statistics as Topic , Still's Disease, Adult-Onset/epidemiology , Still's Disease, Adult-Onset/physiopathology
20.
Ryumachi ; 32(1): 27-38, 1992 Feb.
Article in Japanese | MEDLINE | ID: mdl-1604413

ABSTRACT

A 1987 questionnaire sponsored by the Health and Welfare Ministry concerning the clinical subsets and severity of systemic lupus erythematosus (SLE) was distributed to 93 medial facilities. A clinical analysis of the outcome and treatments was accomplished on one thousand six hundred and fourteen SLE patients fulfilling ARA criteria. The outcome was evaluated into 6 categories, namely; complete remission, incomplete remission, no change, gradual worsening, rapid worsening and unknown. Treatments included (1) anti-inflammatory drugs, (2) initial dose of prednisolone (PSL) below 29 mg/day, (3) initial dose of PSL from 30 to 59 mg/day, (4) initial dose of PSL above 60 mg/day, (5) pulse therapy, (6) immunosuppressants, (7) plasmapheresis, and (8) hemodialysis. Statistical significances were determined with ridit analysis. The severity of the disease for 1,614 SLE patients was evaluated by the judgement of each medical facility independently, separating it into 3 grades. As a result, 16.8% was evaluated as severe, 54.6% was evaluated as moderate, and 28.6% was evaluated as mild. Clinical subsets were divided into 3 categories according to the outcome; (1) those with high complete remission rates (serositis, convulsion, oral ulcers, unconsciousness, hemolytic anemia and so on), (2) those with high incomplete remission rates (lupus nephritis, digital gangrene, hypertension, peripheral neuropathy, erythema, Raynaud's phenomenon and so on), and (3) those with high rates of no change or worsening (aseptic bone necrosis, pulmonary hypertension, pneumonitis, chronic renal failure and so on). SLE patients with persistent proteinuria below 3.4 g/day, pulmonary hypertension, or pneumonitis treated with large doses of PSL such as an initial dose of PSL above 60 mg/day and/or pulse therapy had a significantly higher remission rate than those treated with small dosages of PSL. Hereafter, the establishment of modes of treatments for increasing the remission rates of intractable clinical subsets in highly desired.


Subject(s)
Lupus Erythematosus, Systemic/classification , Adolescent , Adult , Child , Humans , Immunosuppressive Agents/therapeutic use , Japan , Lupus Erythematosus, Systemic/physiopathology , Lupus Erythematosus, Systemic/therapy , Plasmapheresis , Prednisolone/administration & dosage , Renal Dialysis , Surveys and Questionnaires , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...